XML 12 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2017
Mar. 31, 2017
ASSETS    
Cash and cash equivalents $ 31,206,495 $ 8,664,211
Accounts receivable, net of allowance for doubtful accounts of $461,650 and $475,080, respectively 5,423,618 5,506,472
Other receivables 806,148 464,085
Due from affiliates 0 18,314
Prepaid expenses and other current assets 282,732 269,168
Total current assets 37,718,993 14,922,250
Property and equipment, net 1,167,680 1,205,139
Restricted cash 745,117 765,058
Intangible assets, net 1,822,542 1,904,269
Goodwill 1,622,483 1,622,483
Other assets 221,979 225,358
TOTAL ASSETS 43,298,794 20,644,557
LIABILITIES AND STOCKHOLDERS’ EQUITY    
Accounts payable and accrued liabilities 16,212,983 7,883,373
Medical liabilities 19,718,135 1,768,231
Convertible note payable, net of debt issuance cost of $107,333 and $161,000, respectively 4,882,667 4,829,000
Lines of credit 25,000 62,500
Total current liabilities 40,838,785 14,543,104
Note payable - related party 5,000,000 5,000,000
Deferred rent liability 715,462 747,418
Deferred tax liability 83,667 83,667
TOTAL LIABILITIES 46,637,914 20,374,189
COMMITMENTS AND CONTINGENCIES (see Note 8)
STOCKHOLDERS’ (DEFICIT) EQUITY    
Common stock, par value $0.001; 100,000,000 shares authorized, 6,033,518 shares issued and outstanding 6,033 6,033
Additional paid-in capital 26,555,514 26,331,948
Accumulated deficit (41,266,193) (37,654,381)
Stockholders’ deficit attributable to Apollo Medical Holdings, Inc. (3,742,123) (353,877)
Non-controlling interest 403,003 624,245
Total stockholders’ (deficit) equity (3,339,120) 270,368
TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY 43,298,794 20,644,557
Series A Preferred Stock [Member]    
STOCKHOLDERS’ (DEFICIT) EQUITY    
Preferred Stock Value 7,077,778 7,077,778
Series B Preferred Stock [Member]    
STOCKHOLDERS’ (DEFICIT) EQUITY    
Preferred Stock Value $ 3,884,745 $ 3,884,745